Shahab, L;
(2013)
Cardiovascular disease and varenicline (Champix).
(Briefings: 4
).
NCSCT: London, UK.
Preview |
Text
B4_cardiovascular_varenicline.pdf Download (94kB) | Preview |
Abstract
Whilst findings were not uniform, based on the findings of these reviews, the risk of cardiovascular events associated with the use of varenicline is judged to be minimal and clinically insignificant. Note: The recent changes to the service product characteristics (SPC) for varenicline do not substantially change the points raised in this briefing nor the advice that it is safe and effective.
| Type: | Report |
|---|---|
| Title: | Cardiovascular disease and varenicline (Champix) |
| Open access status: | An open access version is available from UCL Discovery |
| Publisher version: | https://www.ncsct.co.uk/publication_cardiovascular... |
| Language: | English |
| Additional information: | This version is the version of record. For information on re-use, please refer to the publisher’s terms and conditions. |
| UCL classification: | UCL UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Population Health Sciences UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Population Health Sciences > Institute of Epidemiology and Health UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Population Health Sciences > Institute of Epidemiology and Health > Behavioural Science and Health |
| URI: | https://discovery.ucl.ac.uk/id/eprint/10083099 |
Downloads since deposit
15Downloads
Download activity - last month
Download activity - last 12 months
Downloads by country - last 12 months
Archive Staff Only
 |
View Item |
